Abbott's Charan on AVEIR DR pacemaker's FDA approval and its potential to revolutionize cardiac care

In the newest episode of AbbottTalks, Vish Charan, divisional VP of product development at Abbott, takes us through the inner workings of the recently FDA-approved AVEIR™ DR Dual Chamber Leadless Pacemaker System, from its inception to its successful clinical trial and FDA approval.

Charan also dives deep into the technology, revealing the cutting-edge i2i communication technology that powers AVEIR™ pacemakers, enabling seamless communication between devices for dual chamber pacing and AV synchrony.

Finally, Charan discusses the challenges of miniaturization, the remarkable advancements in battery technology that have made the AVEIR™ pacemaker possible, and the potential for further applications in conduction system pacing.

As the field of cardiac rhythm management continues to evolve, Charan envisions a future of smaller devices, more features, and enhanced patient care. Make sure to listen in for invaluable insights into the groundbreaking AVEIR™ DR and its potential to transform the landscape of cardiac care.

Thank you to Resonant Link for sponsoring this episode of AbbottTalks. For more information about Resonant Link go to www.Resonant-Link.com.

Thank you for listening to the AbbottTalks Podcast.